Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company,…
Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development
MONMOUTH JUNCTION, N.J., May 13, 2026 /PRNewswire/ — Creatv Bio, a Division of Creatv MicroTech, Inc. (“Creatv”), a…
Function Acquires SuppCo to Bring Trust and Clarity to Supplements
Function helps reveal what is happening inside your body. SuppCo brings the same clarity to what you put…
Delphi Diagnostics Announces New Publication in the European Journal of Cancer
Peer-reviewed manuscript demonstrates the Endocrine Activity IndexTM Recurrence Risk (EAIRR) enhances risk stratification beyond Recurrence Score® and is predictive…
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients…
ANSR Announces ANSR MedTech, a Global Capability Center for a High-Growth MedTech Company
The innovation hub in India will power next-generation healthcare platforms and accelerate global MedTech innovation for a Fortune…
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company…
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama
Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly’s oral GLP-1,…
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Partnership unites Illumina’s leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for…
Breakthrough T1D-Led Paper Outlines First International Consensus Guidance for Continuous Ketone Monitoring in Diabetes
Framework provides recommendations for effective CKM use for those at risk of diabetic ketoacidosis NEW YORK, Dec. 10,…
Lin Health Raises $11 Million Series A to Fuel Growth of Virtual Chronic Pain Recovery Platform
Oversubscribed round demonstrates strong investor confidence in Lin Health’s neuroscience-based approach to chronic pain DENVER, Dec. 9, 2025…